Just following up on my previous post I still stand by my POVs however RVX needs operating funds. I'm not sure how far the previous $10 million will carry to keep funding BoM.

The press release states

• Strategic Transaction
• The Company also announces that it has received a letter of intent regarding a significant potential regional licensing arrangement (the "License") for apabetalone (RVX-208), and/or a significant equity investment in the Company. The License is expected to include an upfront payment and on-going milestone and royalty payments. Management will continue to diligently pursue this opportunity. Additional licensing opportunities are also in discussion.

So it may not be a regional deal and this leaves the door open for a CVR type deal. If it turns out to be a significant regional deal it will add to the downstream potential. This in turn seems to suggest it is not a BP deal unless one wants to buy in on a restricted basis.

I don't know but this seems vague and there are only 4 months to go. Let's hope the FA passes. If the deal gets done I have no idea of the share price may be impacted but I am sensing retail shareholders may not do well in this...just a feeling on my part.

GLTA

Toinv